Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The study will assess the efficacy of EP2006 compared to Filgrastim with respect to the mean duration of severe neutropenia during treatment with myelosuppressive chemotherapy in breast cancer patients.
Epistemonikos ID: 824851e974758f4fee8d3dfd3c400ef018a2b7a6
First added on: May 10, 2024